

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pattern specification involved in kidney development (GO:0061004) | 9.85811910 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 8.41813583 |
| 3 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 8.09979753 |
| 4 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 7.78892092 |
| 5 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 7.69154858 |
| 6 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 7.55492797 |
| 7 | acyl-CoA biosynthetic process (GO:0071616) | 7.36934084 |
| 8 | thioester biosynthetic process (GO:0035384) | 7.36934084 |
| 9 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 7.23531040 |
| 10 | lactation (GO:0007595) | 7.13898284 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 6.84764401 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 6.69553959 |
| 13 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.57385187 |
| 14 | sterol catabolic process (GO:0016127) | 6.56696311 |
| 15 | cholesterol catabolic process (GO:0006707) | 6.56696311 |
| 16 | linoleic acid metabolic process (GO:0043651) | 6.51677445 |
| 17 | positive regulation of p38MAPK cascade (GO:1900745) | 6.47168999 |
| 18 | mammary gland epithelial cell differentiation (GO:0060644) | 6.40946464 |
| 19 | regulation of phospholipid biosynthetic process (GO:0071071) | 6.31169315 |
| 20 | phospholipid homeostasis (GO:0055091) | 6.22931540 |
| 21 | nucleoside transmembrane transport (GO:1901642) | 6.03877954 |
| 22 | ectoderm development (GO:0007398) | 6.03753156 |
| 23 | secretion by tissue (GO:0032941) | 5.91472306 |
| 24 | carnitine shuttle (GO:0006853) | 5.88139461 |
| 25 | intestinal absorption (GO:0050892) | 5.83513121 |
| 26 | fatty acid transmembrane transport (GO:1902001) | 5.81146730 |
| 27 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.78358412 |
| 28 | biotin metabolic process (GO:0006768) | 5.54216176 |
| 29 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.42126862 |
| 30 | ceramide catabolic process (GO:0046514) | 5.30371346 |
| 31 | negative regulation of protein kinase B signaling (GO:0051898) | 5.22496453 |
| 32 | segment specification (GO:0007379) | 5.19984352 |
| 33 | N-acetylneuraminate metabolic process (GO:0006054) | 5.06608768 |
| 34 | mitochondrial calcium ion transport (GO:0006851) | 4.99263198 |
| 35 | body fluid secretion (GO:0007589) | 4.92361271 |
| 36 | tooth mineralization (GO:0034505) | 4.91197126 |
| 37 | positive regulation of osteoblast proliferation (GO:0033690) | 4.84569065 |
| 38 | O-glycan processing (GO:0016266) | 4.78831356 |
| 39 | embryonic process involved in female pregnancy (GO:0060136) | 4.77619984 |
| 40 | regulation of acrosome reaction (GO:0060046) | 4.68783851 |
| 41 | nucleobase catabolic process (GO:0046113) | 4.61851376 |
| 42 | negative regulation of endothelial cell proliferation (GO:0001937) | 4.61739035 |
| 43 | nucleoside transport (GO:0015858) | 4.61009764 |
| 44 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.58740908 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 4.50640169 |
| 46 | GDP-mannose metabolic process (GO:0019673) | 4.49064482 |
| 47 | folic acid transport (GO:0015884) | 4.48460505 |
| 48 | regulation of p38MAPK cascade (GO:1900744) | 4.40421956 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.33428457 |
| 50 | regulation of penile erection (GO:0060405) | 4.33389977 |
| 51 | growth hormone receptor signaling pathway (GO:0060396) | 4.33169822 |
| 52 | carnitine transmembrane transport (GO:1902603) | 4.32538359 |
| 53 | triglyceride biosynthetic process (GO:0019432) | 4.31066940 |
| 54 | phagocytosis, recognition (GO:0006910) | 4.28682339 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 4.28328987 |
| 56 | acylglycerol biosynthetic process (GO:0046463) | 4.17294613 |
| 57 | neutral lipid biosynthetic process (GO:0046460) | 4.17294613 |
| 58 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.16584315 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.11347018 |
| 60 | response to host immune response (GO:0052572) | 4.11347018 |
| 61 | lipid storage (GO:0019915) | 4.07942098 |
| 62 | coenzyme A biosynthetic process (GO:0015937) | 4.03086967 |
| 63 | tricarboxylic acid metabolic process (GO:0072350) | 3.99296073 |
| 64 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.98516343 |
| 65 | response to phenylpropanoid (GO:0080184) | 3.97961199 |
| 66 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.95280625 |
| 67 | copper ion transport (GO:0006825) | 3.92770284 |
| 68 | long-chain fatty acid transport (GO:0015909) | 3.92554310 |
| 69 | carnitine transport (GO:0015879) | 3.90512107 |
| 70 | amino-acid betaine transport (GO:0015838) | 3.90512107 |
| 71 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.89738378 |
| 72 | Golgi transport vesicle coating (GO:0048200) | 3.85492108 |
| 73 | COPI coating of Golgi vesicle (GO:0048205) | 3.85492108 |
| 74 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 3.83410528 |
| 75 | positive regulation of macrophage cytokine production (GO:0060907) | 3.82682953 |
| 76 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.77684195 |
| 77 | negative regulation of epithelial cell differentiation (GO:0030857) | 3.76473463 |
| 78 | regulation of triglyceride metabolic process (GO:0090207) | 3.76472235 |
| 79 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.73500704 |
| 80 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.71392476 |
| 81 | negative regulation of lipid catabolic process (GO:0050995) | 3.71192980 |
| 82 | regulation of endothelial cell differentiation (GO:0045601) | 3.70072238 |
| 83 | glutathione biosynthetic process (GO:0006750) | 3.69407924 |
| 84 | oligosaccharide metabolic process (GO:0009311) | 3.66730202 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.64803383 |
| 86 | response to host (GO:0075136) | 3.64803383 |
| 87 | response to host defenses (GO:0052200) | 3.64803383 |
| 88 | cellular response to growth hormone stimulus (GO:0071378) | 3.62514278 |
| 89 | intracellular lipid transport (GO:0032365) | 3.62494110 |
| 90 | negative regulation of fatty acid transport (GO:2000192) | 3.62168562 |
| 91 | regulation of macrophage cytokine production (GO:0010935) | 3.58331360 |
| 92 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.57593604 |
| 93 | zinc ion transport (GO:0006829) | 3.55033777 |
| 94 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.53577001 |
| 95 | galactose metabolic process (GO:0006012) | 3.52843467 |
| 96 | regulation of vasculogenesis (GO:2001212) | 3.52324390 |
| 97 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.51743142 |
| 98 | fatty acid transport (GO:0015908) | 3.51700088 |
| 99 | cellular carbohydrate biosynthetic process (GO:0034637) | 3.48490900 |
| 100 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.48018273 |
| 101 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.46463803 |
| 102 | regulation of execution phase of apoptosis (GO:1900117) | 3.41860115 |
| 103 | detection of molecule of bacterial origin (GO:0032490) | 3.38464646 |
| 104 | angiogenesis involved in wound healing (GO:0060055) | 3.36748763 |
| 105 | proximal/distal pattern formation (GO:0009954) | 3.36557473 |
| 106 | transcytosis (GO:0045056) | 3.30860033 |
| 107 | purine nucleobase metabolic process (GO:0006144) | 3.28469091 |
| 108 | positive regulation of chemokine secretion (GO:0090197) | 3.24907647 |
| 109 | low-density lipoprotein particle clearance (GO:0034383) | 3.24003840 |
| 110 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.21938832 |
| 111 | positive regulation of lipid storage (GO:0010884) | 3.20948930 |
| 112 | positive regulation of tissue remodeling (GO:0034105) | 3.19790092 |
| 113 | valine metabolic process (GO:0006573) | 3.19720119 |
| 114 | mitochondrion distribution (GO:0048311) | 3.19039876 |
| 115 | sphingolipid catabolic process (GO:0030149) | 3.18842287 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 3.17562517 |
| 117 | branched-chain amino acid metabolic process (GO:0009081) | 3.15335714 |
| 118 | temperature homeostasis (GO:0001659) | 3.14226767 |
| 119 | protein O-linked glycosylation (GO:0006493) | 3.12653293 |
| 120 | regulation of cholesterol storage (GO:0010885) | 3.12159638 |
| 121 | hemidesmosome assembly (GO:0031581) | 3.11479144 |
| 122 | sialylation (GO:0097503) | 3.09780638 |
| 123 | mammary gland development (GO:0030879) | 3.08527202 |
| 124 | cellular response to vitamin D (GO:0071305) | 3.08025290 |
| 125 | acyl-CoA metabolic process (GO:0006637) | 3.06816238 |
| 126 | thioester metabolic process (GO:0035383) | 3.06816238 |
| 127 | branched-chain amino acid catabolic process (GO:0009083) | 3.05619788 |
| 128 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.02297241 |
| 129 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.02297241 |
| 130 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.02297241 |
| 131 | urate metabolic process (GO:0046415) | 3.02224532 |
| 132 | regulation of fatty acid oxidation (GO:0046320) | 2.99798481 |
| 133 | regulation of chemokine secretion (GO:0090196) | 2.98476335 |
| 134 | steroid catabolic process (GO:0006706) | 2.96153120 |
| 135 | heme transport (GO:0015886) | 2.95556139 |
| 136 | regulation of triglyceride catabolic process (GO:0010896) | 2.95527140 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.94687957 |
| 138 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.94687957 |
| 139 | regulation of lipid storage (GO:0010883) | 2.94143683 |
| 140 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.92855493 |
| 141 | coenzyme A metabolic process (GO:0015936) | 2.92055528 |
| 142 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.90598420 |
| 143 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.90598420 |
| 144 | iron ion import (GO:0097286) | 2.90379931 |
| 145 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.88534571 |
| 146 | type B pancreatic cell proliferation (GO:0044342) | 2.87996508 |
| 147 | membrane lipid catabolic process (GO:0046466) | 2.83735587 |
| 148 | acrosome assembly (GO:0001675) | 2.80355922 |
| 149 | short-chain fatty acid metabolic process (GO:0046459) | 2.79152179 |
| 150 | negative regulation of cell fate commitment (GO:0010454) | 2.78561302 |
| 151 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.77941306 |
| 152 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.65729466 |
| 153 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.65443602 |
| 154 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.52464414 |
| 155 | peptide biosynthetic process (GO:0043043) | 2.50943725 |
| 156 | negative regulation of leukocyte migration (GO:0002686) | 2.49651683 |
| 157 | digestive system process (GO:0022600) | 2.48103825 |
| 158 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.45811243 |
| 159 | triglyceride metabolic process (GO:0006641) | 2.43274100 |
| 160 | citrulline biosynthetic process (GO:0019240) | 2.42742434 |
| 161 | pantothenate metabolic process (GO:0015939) | 2.42660422 |
| 162 | oligosaccharide biosynthetic process (GO:0009312) | 12.4606204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 7.86015121 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 5.58383116 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.05858301 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80787962 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 4.11220803 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.56967735 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.28207665 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07761782 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.94758011 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.74452800 |
| 11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.51269957 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.18907877 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18205439 |
| 14 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.18026994 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02695429 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00163360 |
| 17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.98721144 |
| 18 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.97666527 |
| 19 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.97506297 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96206764 |
| 21 | RXR_22108803_ChIP-Seq_LS180_Human | 1.95226059 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87806762 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.83979012 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80233417 |
| 25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79945561 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76283390 |
| 27 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.75869262 |
| 28 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.74503814 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71143420 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70998631 |
| 31 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.68774632 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59805413 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59802736 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58894039 |
| 35 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.58316294 |
| 36 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.53607602 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52918528 |
| 38 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.50747979 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50364111 |
| 40 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.49733594 |
| 41 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.49716482 |
| 42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46291373 |
| 43 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45128535 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44742130 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43892352 |
| 46 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.43799376 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41036948 |
| 48 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40672348 |
| 49 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39314943 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38392884 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38199755 |
| 52 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36217331 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35931820 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31873241 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31755939 |
| 56 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.30190255 |
| 57 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.29909624 |
| 58 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29761269 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29689763 |
| 60 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28035999 |
| 61 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26794468 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25743429 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25742207 |
| 64 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.25453888 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24554277 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22233295 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22015604 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21362691 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19551514 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18946678 |
| 71 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17635445 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17302996 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16599128 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16096380 |
| 75 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15615993 |
| 76 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.14618568 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12858596 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12836565 |
| 79 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.12607842 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12549113 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12014324 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11349480 |
| 83 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11226124 |
| 84 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.11118345 |
| 85 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10168065 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09528414 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08102463 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07938700 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06189587 |
| 90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05055145 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05055145 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04915684 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04764996 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04679381 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04590926 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04108904 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01587502 |
| 98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01587502 |
| 99 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.01526605 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01034001 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00857170 |
| 102 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99171187 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98825599 |
| 104 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98484469 |
| 105 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97588930 |
| 106 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.97202945 |
| 107 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97027341 |
| 108 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96763389 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95963773 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95259768 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94490438 |
| 112 | NFYA_21822215_ChIP-Seq_K562_Human | 0.93399078 |
| 113 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93254208 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92712177 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91732040 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91267566 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91267566 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91175610 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90510177 |
| 120 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.90425586 |
| 121 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.90012884 |
| 122 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89869725 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89722605 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89262376 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88697395 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.87542992 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87046117 |
| 128 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86900476 |
| 129 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86771046 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86607471 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86577951 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86548345 |
| 133 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86191977 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86182723 |
| 135 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.85629989 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.85603354 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85545505 |
| 138 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85367359 |
| 139 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84838642 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84165635 |
| 141 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.84139782 |
| 142 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83826923 |
| 143 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83576863 |
| 144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81664764 |
| 145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81285697 |
| 146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81061554 |
| 147 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80781784 |
| 148 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.79703458 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79598510 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79403709 |
| 151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79041519 |
| 152 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78788943 |
| 153 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.78696947 |
| 154 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77969453 |
| 155 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77911393 |
| 156 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.77435172 |
| 157 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.76781633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.38850145 |
| 2 | MP0002254_reproductive_system_inflammat | 3.69921892 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.41941655 |
| 4 | MP0003136_yellow_coat_color | 3.28221506 |
| 5 | * MP0000627_abnormal_mammary_gland | 3.27279978 |
| 6 | MP0005083_abnormal_biliary_tract | 3.21548823 |
| 7 | MP0003718_maternal_effect | 3.10096797 |
| 8 | MP0003303_peritoneal_inflammation | 2.86752355 |
| 9 | MP0001873_stomach_inflammation | 2.84971853 |
| 10 | MP0004147_increased_porphyrin_level | 2.84926304 |
| 11 | MP0004130_abnormal_muscle_cell | 2.69358062 |
| 12 | MP0003011_delayed_dark_adaptation | 2.58183240 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.55853055 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.48444079 |
| 15 | MP0002796_impaired_skin_barrier | 2.04641132 |
| 16 | * MP0001881_abnormal_mammary_gland | 12.0901797 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 1.98905601 |
| 18 | MP0005395_other_phenotype | 1.85116971 |
| 19 | MP0002098_abnormal_vibrissa_morphology | 1.70630252 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 1.68758306 |
| 21 | MP0004043_abnormal_pH_regulation | 1.68577540 |
| 22 | MP0002009_preneoplasia | 1.66387442 |
| 23 | MP0005666_abnormal_adipose_tissue | 1.66351596 |
| 24 | MP0005360_urolithiasis | 1.63883142 |
| 25 | MP0005410_abnormal_fertilization | 1.59735753 |
| 26 | MP0005670_abnormal_white_adipose | 1.59277348 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.38029892 |
| 28 | MP0001664_abnormal_digestion | 1.31483390 |
| 29 | MP0000678_abnormal_parathyroid_gland | 1.28809762 |
| 30 | MP0008004_abnormal_stomach_pH | 1.26942088 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.26671629 |
| 32 | MP0000377_abnormal_hair_follicle | 1.25559515 |
| 33 | MP0005171_absent_coat_pigmentation | 1.24984354 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.21829178 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.21800249 |
| 36 | MP0008260_abnormal_autophagy | 1.20251656 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.18639315 |
| 38 | MP0005501_abnormal_skin_physiology | 1.18566012 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.16936439 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.12628891 |
| 41 | MP0000490_abnormal_crypts_of | 1.11181430 |
| 42 | MP0003936_abnormal_reproductive_system | 1.10853472 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.08274650 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.07775488 |
| 45 | MP0004272_abnormal_basement_membrane | 1.07711531 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.07647833 |
| 47 | MP0009764_decreased_sensitivity_to | 1.01319427 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.00290171 |
| 49 | MP0002168_other_aberrant_phenotype | 0.97504312 |
| 50 | MP0003045_fibrosis | 0.96234520 |
| 51 | MP0001663_abnormal_digestive_system | 0.92980122 |
| 52 | MP0002896_abnormal_bone_mineralization | 0.90877373 |
| 53 | MP0005076_abnormal_cell_differentiation | 0.90053485 |
| 54 | MP0002971_abnormal_brown_adipose | 0.88484475 |
| 55 | MP0005448_abnormal_energy_balance | 0.88048984 |
| 56 | MP0005334_abnormal_fat_pad | 0.86692308 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 0.85803524 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.82470265 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 0.81199698 |
| 60 | MP0003448_altered_tumor_morphology | 0.80954422 |
| 61 | MP0001849_ear_inflammation | 0.79661530 |
| 62 | MP0002970_abnormal_white_adipose | 0.79210871 |
| 63 | MP0001216_abnormal_epidermal_layer | 0.79172399 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.78591686 |
| 65 | MP0001177_atelectasis | 0.77223814 |
| 66 | MP0005275_abnormal_skin_tensile | 0.76242995 |
| 67 | MP0009278_abnormal_bone_marrow | 0.74022443 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73005868 |
| 69 | MP0005381_digestive/alimentary_phenotyp | 0.72873013 |
| 70 | MP0001727_abnormal_embryo_implantation | 0.72307741 |
| 71 | MP0005535_abnormal_body_temperature | 0.72025909 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 0.71515483 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.70476570 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.70172756 |
| 75 | MP0009379_abnormal_foot_pigmentation | 0.69547711 |
| 76 | MP0002282_abnormal_trachea_morphology | 0.69229092 |
| 77 | MP0005365_abnormal_bile_salt | 0.68658570 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.67518573 |
| 79 | MP0001984_abnormal_olfaction | 0.67245842 |
| 80 | MP0000613_abnormal_salivary_gland | 0.65828266 |
| 81 | MP0003950_abnormal_plasma_membrane | 0.65645311 |
| 82 | MP0005023_abnormal_wound_healing | 0.65251255 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.64671234 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.64479120 |
| 85 | MP0004924_abnormal_behavior | 0.64479120 |
| 86 | MP0004947_skin_inflammation | 0.64442228 |
| 87 | MP0008770_decreased_survivor_rate | 0.64250441 |
| 88 | MP0000609_abnormal_liver_physiology | 0.63576202 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.62056921 |
| 90 | MP0002060_abnormal_skin_morphology | 0.62007542 |
| 91 | MP0003787_abnormal_imprinting | 0.60791231 |
| 92 | MP0001851_eye_inflammation | 0.59036825 |
| 93 | MP0009931_abnormal_skin_appearance | 0.56222299 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.55939547 |
| 95 | MP0000427_abnormal_hair_cycle | 0.55424362 |
| 96 | MP0003075_altered_response_to | 0.55197921 |
| 97 | MP0005164_abnormal_response_to | 0.53486565 |
| 98 | MP0002148_abnormal_hypersensitivity_rea | 0.53391345 |
| 99 | MP0005452_abnormal_adipose_tissue | 0.53385349 |
| 100 | MP0000858_altered_metastatic_potential | 0.53264138 |
| 101 | MP0003699_abnormal_female_reproductive | 0.52497299 |
| 102 | MP0005408_hypopigmentation | 0.52292536 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.51067309 |
| 104 | MP0005332_abnormal_amino_acid | 0.50789452 |
| 105 | MP0004883_abnormal_blood_vessel | 0.50051336 |
| 106 | MP0003948_abnormal_gas_homeostasis | 0.49508863 |
| 107 | MP0004858_abnormal_nervous_system | 0.48462945 |
| 108 | MP0003953_abnormal_hormone_level | 0.47678049 |
| 109 | MP0001958_emphysema | 0.47203588 |
| 110 | MP0010771_integument_phenotype | 0.46842478 |
| 111 | MP0009763_increased_sensitivity_to | 0.46576037 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.46474072 |
| 113 | MP0002133_abnormal_respiratory_system | 0.46046992 |
| 114 | MP0005388_respiratory_system_phenotype | 0.46046992 |
| 115 | MP0003795_abnormal_bone_structure | 0.45988484 |
| 116 | MP0003959_abnormal_lean_body | 0.45506075 |
| 117 | MP0005165_increased_susceptibility_to | 0.44927543 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.44586117 |
| 119 | MP0000759_abnormal_skeletal_muscle | 0.43902559 |
| 120 | MP0005385_cardiovascular_system_phenoty | 0.43661595 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.43661595 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.42490907 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.42370091 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.41310474 |
| 125 | MP0000013_abnormal_adipose_tissue | 0.41200962 |
| 126 | MP0003690_abnormal_glial_cell | 0.40381882 |
| 127 | MP0002135_abnormal_kidney_morphology | 0.39647015 |
| 128 | MP0000579_abnormal_nail_morphology | 0.39574235 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.38132159 |
| 130 | MP0005451_abnormal_body_composition | 0.37343918 |
| 131 | MP0009785_altered_susceptibility_to | 0.34728773 |
| 132 | MP0008789_abnormal_olfactory_epithelium | 0.33776952 |
| 133 | MP0001756_abnormal_urination | 0.33669788 |
| 134 | MP0008874_decreased_physiological_sensi | 0.32860594 |
| 135 | MP0000371_diluted_coat_color | 0.32519138 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.32425452 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.28781342 |
| 138 | MP0003195_calcinosis | 0.28651157 |
| 139 | MP0005394_taste/olfaction_phenotype | 0.28558600 |
| 140 | MP0005499_abnormal_olfactory_system | 0.28558600 |
| 141 | MP0003984_embryonic_growth_retardation | 0.28116660 |
| 142 | MP0001764_abnormal_homeostasis | 0.28060011 |
| 143 | MP0001853_heart_inflammation | 0.27291859 |
| 144 | MP0009333_abnormal_splenocyte_physiolog | 0.26986000 |
| 145 | MP0002088_abnormal_embryonic_growth/wei | 0.26118954 |
| 146 | MP0001542_abnormal_bone_strength | 0.26058075 |
| 147 | MP0002419_abnormal_innate_immunity | 0.25862203 |
| 148 | MP0002693_abnormal_pancreas_physiology | 0.25629639 |
| 149 | MP0002089_abnormal_postnatal_growth/wei | 0.25088893 |
| 150 | MP0000598_abnormal_liver_morphology | 0.24066918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 6.89603577 |
| 2 | Decreased circulating renin level (HP:0003351) | 6.66408211 |
| 3 | Abnormality of purine metabolism (HP:0004352) | 6.55396619 |
| 4 | Amelogenesis imperfecta (HP:0000705) | 6.52032588 |
| 5 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.52190580 |
| 6 | Gout (HP:0001997) | 5.34465316 |
| 7 | Axonal loss (HP:0003447) | 5.23667228 |
| 8 | Tubulointerstitial nephritis (HP:0001970) | 4.77577954 |
| 9 | Thin bony cortex (HP:0002753) | 4.63922636 |
| 10 | Hypokalemic alkalosis (HP:0001949) | 4.48337826 |
| 11 | Overgrowth (HP:0001548) | 4.40414151 |
| 12 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.34796322 |
| 13 | Ectropion (HP:0000656) | 4.24218488 |
| 14 | Pili torti (HP:0003777) | 4.09274652 |
| 15 | Epidermoid cyst (HP:0200040) | 4.08782146 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.00036265 |
| 17 | Hyperkalemia (HP:0002153) | 3.99767449 |
| 18 | Abnormality of nucleobase metabolism (HP:0010932) | 3.98310870 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.96438031 |
| 20 | Chronic bronchitis (HP:0004469) | 3.90515072 |
| 21 | Hydronephrosis (HP:0000126) | 3.85630457 |
| 22 | Curly hair (HP:0002212) | 3.83319787 |
| 23 | Metaphyseal dysplasia (HP:0100255) | 3.82073921 |
| 24 | Nephritis (HP:0000123) | 3.79602387 |
| 25 | Enlarged epiphyses (HP:0010580) | 3.78936843 |
| 26 | Hyperaldosteronism (HP:0000859) | 3.69080767 |
| 27 | Aortic aneurysm (HP:0004942) | 3.59718310 |
| 28 | Myocardial infarction (HP:0001658) | 3.59329678 |
| 29 | Abnormality of renal excretion (HP:0011036) | 3.53785325 |
| 30 | Subcapsular cataract (HP:0000523) | 3.47539010 |
| 31 | Stridor (HP:0010307) | 3.41471935 |
| 32 | Onycholysis (HP:0001806) | 3.28941009 |
| 33 | Abnormality of renal resorption (HP:0011038) | 3.22205199 |
| 34 | Tubulointerstitial fibrosis (HP:0005576) | 3.19910653 |
| 35 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.17139888 |
| 36 | Skin nodule (HP:0200036) | 3.17099402 |
| 37 | Hypotension (HP:0002615) | 3.16617912 |
| 38 | Atrophic scars (HP:0001075) | 3.13560221 |
| 39 | Protuberant abdomen (HP:0001538) | 3.12033049 |
| 40 | Hyponatremia (HP:0002902) | 3.11344943 |
| 41 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.11266625 |
| 42 | Neurodegeneration (HP:0002180) | 3.09624555 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 3.07666091 |
| 44 | Hypoplasia of dental enamel (HP:0006297) | 3.03236347 |
| 45 | Metaphyseal irregularity (HP:0003025) | 2.98040883 |
| 46 | Tubular atrophy (HP:0000092) | 2.95501566 |
| 47 | Xanthomatosis (HP:0000991) | 2.94610136 |
| 48 | Glomerulosclerosis (HP:0000096) | 2.93995428 |
| 49 | Abnormal tarsal ossification (HP:0008369) | 2.93387011 |
| 50 | Abnormal auditory evoked potentials (HP:0006958) | 2.88653913 |
| 51 | Abnormality of chloride homeostasis (HP:0011422) | 2.81198368 |
| 52 | Aplasia cutis congenita (HP:0001057) | 2.77053186 |
| 53 | Nausea (HP:0002018) | 2.76740993 |
| 54 | Milia (HP:0001056) | 2.76067521 |
| 55 | Turricephaly (HP:0000262) | 2.74436133 |
| 56 | Flat acetabular roof (HP:0003180) | 2.69885394 |
| 57 | Hypoplasia of the iris (HP:0007676) | 2.64241398 |
| 58 | Abnormality of the dental pulp (HP:0006479) | 2.61260467 |
| 59 | Aortic dissection (HP:0002647) | 2.60712254 |
| 60 | Delayed epiphyseal ossification (HP:0002663) | 2.59630228 |
| 61 | Bone cyst (HP:0012062) | 2.57965339 |
| 62 | Abnormality of dental color (HP:0011073) | 2.57114665 |
| 63 | Widely patent fontanelles and sutures (HP:0004492) | 2.55290528 |
| 64 | Cortical dysplasia (HP:0002539) | 2.54225708 |
| 65 | Premature skin wrinkling (HP:0100678) | 2.51660993 |
| 66 | Renal salt wasting (HP:0000127) | 2.50395494 |
| 67 | Asymmetry of the thorax (HP:0001555) | 2.50137467 |
| 68 | Adrenal overactivity (HP:0002717) | 2.50119935 |
| 69 | Abnormality of sodium homeostasis (HP:0010931) | 2.50081457 |
| 70 | Increased purine levels (HP:0004368) | 2.47882848 |
| 71 | Hyperuricemia (HP:0002149) | 2.47882848 |
| 72 | Biliary tract neoplasm (HP:0100574) | 2.44145435 |
| 73 | Epiphyseal dysplasia (HP:0002656) | 2.42147585 |
| 74 | Hyperparathyroidism (HP:0000843) | 2.35448825 |
| 75 | Rickets (HP:0002748) | 2.35248198 |
| 76 | Aneurysm (HP:0002617) | 2.32708061 |
| 77 | Enlarged penis (HP:0000040) | 2.31748920 |
| 78 | Abnormal hair laboratory examination (HP:0003328) | 2.30870411 |
| 79 | Cerebral aneurysm (HP:0004944) | 2.30143652 |
| 80 | White forelock (HP:0002211) | 2.30119509 |
| 81 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.28517562 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.27324987 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.21737167 |
| 84 | Wide cranial sutures (HP:0010537) | 2.21226804 |
| 85 | Abdominal distention (HP:0003270) | 2.20889574 |
| 86 | Poor eye contact (HP:0000817) | 2.19004170 |
| 87 | Alkalosis (HP:0001948) | 2.18473600 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.16567407 |
| 89 | Loss of speech (HP:0002371) | 2.14490482 |
| 90 | Tetraparesis (HP:0002273) | 2.14433592 |
| 91 | Autoamputation (HP:0001218) | 2.13782349 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 2.12350998 |
| 93 | Optic neuritis (HP:0100653) | 2.12350998 |
| 94 | Arterial tortuosity (HP:0005116) | 2.11119663 |
| 95 | Metabolic acidosis (HP:0001942) | 2.10172556 |
| 96 | Azoospermia (HP:0000027) | 2.06752027 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 2.06226070 |
| 98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06226070 |
| 99 | Abnormal epiphyseal ossification (HP:0010656) | 2.05609976 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04933391 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 2.04450140 |
| 102 | Hypercholesterolemia (HP:0003124) | 2.02307933 |
| 103 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01921377 |
| 104 | Reduced antithrombin III activity (HP:0001976) | 2.00829609 |
| 105 | Glomerulonephritis (HP:0000099) | 2.00524513 |
| 106 | Buphthalmos (HP:0000557) | 2.00443284 |
| 107 | Abnormality of the anterior chamber (HP:0000593) | 1.99728591 |
| 108 | Patchy hypopigmentation of hair (HP:0011365) | 1.97538171 |
| 109 | Nephrolithiasis (HP:0000787) | 1.97349317 |
| 110 | Hypokalemia (HP:0002900) | 1.94669610 |
| 111 | Sparse lateral eyebrow (HP:0005338) | 1.94192810 |
| 112 | Orchitis (HP:0100796) | 1.94044334 |
| 113 | Abnormality of nail color (HP:0100643) | 1.94010623 |
| 114 | Polar cataract (HP:0010696) | 1.94007390 |
| 115 | Symptomatic seizures (HP:0011145) | 1.93265038 |
| 116 | Exostoses (HP:0100777) | 1.92881311 |
| 117 | Abnormality of the periventricular white matter (HP:0002518) | 1.91261549 |
| 118 | Vascular tortuosity (HP:0004948) | 1.91259075 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 1.91232200 |
| 120 | Alopecia of scalp (HP:0002293) | 1.90825002 |
| 121 | Germ cell neoplasia (HP:0100728) | 1.90478886 |
| 122 | Pustule (HP:0200039) | 1.90005061 |
| 123 | Hypophosphatemia (HP:0002148) | 1.89474108 |
| 124 | Vascular calcification (HP:0004934) | 1.89066623 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.86914438 |
| 126 | Hyperglycinuria (HP:0003108) | 1.86756437 |
| 127 | Paraparesis (HP:0002385) | 1.86499286 |
| 128 | Ketoacidosis (HP:0001993) | 1.86164118 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85833559 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85782510 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.85650807 |
| 132 | Spastic tetraparesis (HP:0001285) | 1.85518013 |
| 133 | Macroorchidism (HP:0000053) | 1.83730370 |
| 134 | Pancreatitis (HP:0001733) | 1.81008338 |
| 135 | Erythroderma (HP:0001019) | 1.80418400 |
| 136 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80060163 |
| 137 | Abnormality of the costochondral junction (HP:0000919) | 1.80037172 |
| 138 | Long toe (HP:0010511) | 1.79436563 |
| 139 | Abnormality of vision evoked potentials (HP:0000649) | 1.78594403 |
| 140 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77287559 |
| 141 | Abnormality of glycine metabolism (HP:0010895) | 1.77287559 |
| 142 | Cortical visual impairment (HP:0100704) | 1.76994755 |
| 143 | Heterochromia iridis (HP:0001100) | 1.76084513 |
| 144 | Hypohidrosis (HP:0000966) | 1.75649877 |
| 145 | Hyperphosphatemia (HP:0002905) | 1.75627130 |
| 146 | Ketosis (HP:0001946) | 1.74801833 |
| 147 | Shallow orbits (HP:0000586) | 1.73100079 |
| 148 | Genu varum (HP:0002970) | 1.72852410 |
| 149 | Postnatal microcephaly (HP:0005484) | 1.72813595 |
| 150 | Epiphyseal stippling (HP:0010655) | 1.72247834 |
| 151 | Rough bone trabeculation (HP:0100670) | 1.71511953 |
| 152 | Impaired social interactions (HP:0000735) | 1.70372611 |
| 153 | Abnormal social behavior (HP:0012433) | 1.70372611 |
| 154 | Hyperglycinemia (HP:0002154) | 1.69892239 |
| 155 | Posterior subcapsular cataract (HP:0007787) | 1.68816561 |
| 156 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66357725 |
| 157 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64281568 |
| 158 | Opisthotonus (HP:0002179) | 1.62284331 |
| 159 | Primary adrenal insufficiency (HP:0008207) | 1.61987389 |
| 160 | Congenital glaucoma (HP:0001087) | 1.61213443 |
| 161 | Asymmetric septal hypertrophy (HP:0001670) | 1.61103877 |
| 162 | Dysostosis multiplex (HP:0000943) | 1.60463624 |
| 163 | Spastic paraparesis (HP:0002313) | 1.60112920 |
| 164 | Flat occiput (HP:0005469) | 1.58091879 |
| 165 | Dehydration (HP:0001944) | 1.57831083 |
| 166 | Increased serum ferritin (HP:0003281) | 1.56393391 |
| 167 | Increased serum pyruvate (HP:0003542) | 1.56279456 |
| 168 | Tubulointerstitial abnormality (HP:0001969) | 1.53139804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 6.64893840 |
| 2 | CAMK1D | 5.65258961 |
| 3 | CAMK1G | 4.40913015 |
| 4 | PKN2 | 4.33989963 |
| 5 | EEF2K | 3.29173681 |
| 6 | TRIB3 | 3.26328911 |
| 7 | ICK | 2.81657723 |
| 8 | MAP2K6 | 2.76598123 |
| 9 | LATS1 | 2.62547585 |
| 10 | PIK3CA | 2.56140128 |
| 11 | PDK3 | 2.47620273 |
| 12 | PDK4 | 2.47620273 |
| 13 | ARAF | 2.43059477 |
| 14 | NME2 | 2.41037229 |
| 15 | TESK1 | 2.27297718 |
| 16 | EPHA3 | 2.22605769 |
| 17 | PTK6 | 2.13670743 |
| 18 | ERN1 | 2.11328862 |
| 19 | STK38L | 2.10420288 |
| 20 | EPHB1 | 1.93935579 |
| 21 | PDGFRB | 1.84934486 |
| 22 | RIPK1 | 1.80085487 |
| 23 | PDK2 | 1.79614239 |
| 24 | MAP3K9 | 1.64703247 |
| 25 | BMPR2 | 1.63514645 |
| 26 | PRKAA2 | 1.60417777 |
| 27 | KSR2 | 1.52347206 |
| 28 | MAPKAPK3 | 1.49215148 |
| 29 | BCKDK | 1.47313483 |
| 30 | TESK2 | 1.40695632 |
| 31 | RET | 1.39240083 |
| 32 | ZAP70 | 1.37103747 |
| 33 | STK16 | 1.37099070 |
| 34 | TGFBR2 | 1.36838408 |
| 35 | SCYL2 | 1.36226910 |
| 36 | BRAF | 1.28238302 |
| 37 | MOS | 1.22532323 |
| 38 | MAP3K7 | 1.19384823 |
| 39 | STK38 | 1.18924214 |
| 40 | MAP3K13 | 1.18604932 |
| 41 | FER | 1.12926240 |
| 42 | TRPM7 | 1.11301538 |
| 43 | MAPKAPK5 | 1.09243869 |
| 44 | DAPK2 | 1.07405228 |
| 45 | FRK | 1.00587827 |
| 46 | RPS6KB2 | 0.98296905 |
| 47 | STK39 | 0.97915196 |
| 48 | RIPK4 | 0.96751451 |
| 49 | PINK1 | 0.94110158 |
| 50 | STK3 | 0.93916168 |
| 51 | CSNK2A2 | 0.87550137 |
| 52 | LRRK2 | 0.86546001 |
| 53 | BMX | 0.81842871 |
| 54 | PRKAA1 | 0.80810248 |
| 55 | EPHA2 | 0.71091674 |
| 56 | CAMK1 | 0.70366348 |
| 57 | JAK3 | 0.69692075 |
| 58 | IRAK4 | 0.69518089 |
| 59 | WNK4 | 0.66286367 |
| 60 | JAK1 | 0.64659698 |
| 61 | PRKCD | 0.64257370 |
| 62 | CAMK2D | 0.64060571 |
| 63 | GSK3A | 0.63967028 |
| 64 | CAMK2G | 0.61978959 |
| 65 | ILK | 0.61693704 |
| 66 | DDR2 | 0.61147266 |
| 67 | TAOK3 | 0.59479978 |
| 68 | IRAK3 | 0.58279349 |
| 69 | MAP2K2 | 0.57544864 |
| 70 | PTK2 | 0.57474207 |
| 71 | JAK2 | 0.57336424 |
| 72 | TAOK2 | 0.56929859 |
| 73 | SGK223 | 0.55090625 |
| 74 | SGK494 | 0.55090625 |
| 75 | LIMK1 | 0.54596533 |
| 76 | IRAK2 | 0.54198270 |
| 77 | MET | 0.53806171 |
| 78 | TAOK1 | 0.53244772 |
| 79 | IGF1R | 0.53211455 |
| 80 | EIF2AK1 | 0.52740424 |
| 81 | NEK9 | 0.52489998 |
| 82 | CDK6 | 0.51979299 |
| 83 | CHUK | 0.51931431 |
| 84 | MYLK | 0.51618776 |
| 85 | MATK | 0.51130244 |
| 86 | MAP3K2 | 0.49265249 |
| 87 | MAPK12 | 0.49000573 |
| 88 | CAMK2B | 0.48802545 |
| 89 | GRK6 | 0.48329561 |
| 90 | CSNK1A1 | 0.48218643 |
| 91 | MTOR | 0.47576170 |
| 92 | NLK | 0.47419846 |
| 93 | IKBKE | 0.47064949 |
| 94 | RPS6KA2 | 0.46982716 |
| 95 | PRKCG | 0.45941390 |
| 96 | FGFR4 | 0.44851312 |
| 97 | GRK7 | 0.44196243 |
| 98 | NEK6 | 0.43620312 |
| 99 | EIF2AK3 | 0.43505006 |
| 100 | EIF2AK2 | 0.42470827 |
| 101 | LMTK2 | 0.40184953 |
| 102 | PIM1 | 0.39134498 |
| 103 | RPS6KB1 | 0.38930187 |
| 104 | NUAK1 | 0.38903117 |
| 105 | FGFR3 | 0.38595094 |
| 106 | TBK1 | 0.37567318 |
| 107 | LATS2 | 0.37078318 |
| 108 | CDK9 | 0.37057153 |
| 109 | RAF1 | 0.36919746 |
| 110 | MAP2K1 | 0.35727500 |
| 111 | PIK3CG | 0.35212888 |
| 112 | CSF1R | 0.34100030 |
| 113 | TYK2 | 0.32839505 |
| 114 | PRKD2 | 0.31493253 |
| 115 | LYN | 0.30318939 |
| 116 | MAPK11 | 0.28564870 |
| 117 | MAP3K1 | 0.24722195 |
| 118 | PAK1 | 0.24648081 |
| 119 | MAP3K8 | 0.23781564 |
| 120 | SMG1 | 0.23454736 |
| 121 | PAK2 | 0.22962282 |
| 122 | PRKD1 | 0.22719005 |
| 123 | TIE1 | 0.22620454 |
| 124 | FLT3 | 0.22147661 |
| 125 | IRAK1 | 0.21571452 |
| 126 | MAP3K3 | 0.20361606 |
| 127 | PDGFRA | 0.19433149 |
| 128 | CASK | 0.19047346 |
| 129 | SRC | 0.18835341 |
| 130 | PRKCZ | 0.18733223 |
| 131 | MST1R | 0.17461123 |
| 132 | MARK3 | 0.17450833 |
| 133 | MAP3K6 | 0.17311930 |
| 134 | WNK1 | 0.15146157 |
| 135 | EGFR | 0.14859748 |
| 136 | PTK2B | 0.14467371 |
| 137 | MAP3K14 | 0.13701329 |
| 138 | PDK1 | 0.13066614 |
| 139 | PDPK1 | 0.12922923 |
| 140 | SGK3 | 0.12171105 |
| 141 | BCR | 0.12099509 |
| 142 | FGR | 0.10548397 |
| 143 | SGK2 | 0.09983818 |
| 144 | BTK | 0.09821809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 9.43582523 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 8.90097851 |
| 3 | Galactose metabolism_Homo sapiens_hsa00052 | 3.46816336 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.91236085 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.43435987 |
| 6 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 2.28114675 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20429852 |
| 8 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.96142066 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.69916088 |
| 10 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.63291436 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55266671 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47698938 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43772489 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.30086771 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16432683 |
| 16 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11549115 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02622869 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00077064 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88342262 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86177182 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84905861 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84798410 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 0.84237449 |
| 24 | Protein export_Homo sapiens_hsa03060 | 0.82081020 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73644191 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72389216 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69157915 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66164080 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65462509 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 0.64218245 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61020815 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58909715 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57640303 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56449007 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54635996 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 0.54235142 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52252994 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50204754 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49717167 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49574806 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49356361 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49102973 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48112219 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48037098 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47850394 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47227374 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47138612 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47126938 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44742132 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44285522 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44110589 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43981615 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.43920550 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43715756 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40992683 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39856884 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38612730 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36526516 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36023657 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.35887931 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35790485 |
| 62 | Tight junction_Homo sapiens_hsa04530 | 0.35389812 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35079722 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34431508 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34097181 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33826357 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.32255842 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32245556 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29901691 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.29872287 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29681239 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.29323634 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29192943 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28862176 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27484047 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.27360609 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27192047 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27109986 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.26594161 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26166218 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.25947335 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25808205 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25656504 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25630606 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.25373968 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24842091 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24570870 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24315301 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23829208 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23733043 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23611977 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23447191 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23087469 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.22855798 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22417960 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21944369 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.21384211 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20525658 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20418276 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.19786579 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.19168178 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19133021 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.18390662 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.18202356 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.16726716 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16367594 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.15992357 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14907129 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14801348 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14286462 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13884446 |
| 112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.13472036 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13372910 |
| 114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.13088095 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12874887 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.12521138 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.12499748 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.11937917 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.11758192 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.11502154 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.10869392 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10284495 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.09192456 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.09141956 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.08956900 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08736840 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.08580997 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.05399350 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01859983 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00560144 |
| 131 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.00297758 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0694788 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0614902 |
| 134 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0572256 |
| 135 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | -0.0557598 |
| 136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0401726 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0253300 |
| 138 | Tryptophan metabolism_Homo sapiens_hsa00380 | -0.0242251 |
| 139 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0191782 |
| 140 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0142132 |

